Rawson, TM;
Brima, N;
Almajid, F;
Pozniak, AL;
Janmohamed, A;
Mandalia, S;
Basnayake, S;
... Miller, RF; + view all
(2015)
Outcomes From Treating Tuberculosis With Rifampicin or Rifabutin in HIV-Infected Persons Also Receiving Antiretroviral Therapy.
[Letter].
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 68
(5)
e84-e87.
10.1097/QAI.0000000000000515.
Preview |
Text
Miller_Rifabutin_Letter_to_the_Editors_JAIDSManuscript.pdf - Accepted Version Download (131kB) | Preview |
Preview |
Text
Miller_Rifabutin_Letter_to_the_Editors_JAIDS_Table.pdf - Accepted Version Download (106kB) | Preview |
Type: | Article |
---|---|
Title: | Outcomes From Treating Tuberculosis With Rifampicin or Rifabutin in HIV-Infected Persons Also Receiving Antiretroviral Therapy |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1097/QAI.0000000000000515 |
Publisher version: | http://dx.doi.org/10.1097/QAI.0000000000000515 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Science & technology, life sciences & biomedicine, immunology, infectious diseases, pulmonary tuberculosis, drug-interactions, combination, resistance, relapse |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/1460439 |
Archive Staff Only
View Item |